In 2023, the mortality rate for bladder malignant neoplasms in Canadian women was at 3.5 deaths per 100,000. The forecast data from 2024 to 2028 indicates a slight uptick to 3.6 in 2024, and stabilizes at 3.7 deaths per 100,000 women for the subsequent years through 2028. This shows a marginal year-on-year increase of 2.8% in 2024, with no further increase expected between 2025 and 2028. The 5-year compound annual growth rate (CAGR) of the forecasted period reflects a minimal average annual increase of approximately 1.1%.
Future trends to watch for include advancements in medical technology and treatments that could influence mortality rates. Additionally, societal shifts such as changes in smoking prevalence and other lifestyle risk factors could impact future forecasts.
